Bias in uncontrolled therapeutic trials in rheumatology due to selection of populations with extreme characteristics. — John P A Ioannidis (2001) | RDL Network
Several recent uncontrolled trials of therapeutic interventions in rheumatology are subject to biases stemming from the selection of patients with extreme characteristics. Baseline evaluations separate from the screening measurements should be performed and eligibility criteria and outcomes should be carefully defined.
Konstantinos K. Tsilidis, Orestis A. Panagiotou, Emily S. Sena, Eleni Aretouli, Εvangelos Εvangelou, David W. Howells, Rustam Al‐Shahi Salman, Malcolm Macleod, John P A Ioannidis
Kristian Thorlund, Davey M. Smith, Christopher Linsell, Sir Nicholas White, Christopher Butler, David R. Boulware, Judith S. Currier, Ofir Harari, Edouard Lhomme, Nathalie Strub‐Wourgaft, Stacey J. Adam, Edward J. Mills
Discussion(0)
No comments yet. Be the first to comment.